The clinical significance of IgM antibodies has been evaluated in fields such as infection, autoimmune diseases and cancers, and their potential organ-protective and anti-inflammatory effects, as well as utility in evaluating pathological conditions, have been reported. This evidence concerns the gene CD40LG and autoimmune disease.